Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Breast Carcinoma Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Breast Carcinoma|Receptor, ErbB-2
Interventions: DRUG: 68GaNOTA-Anti-HER2 VHH1
Sponsor: Universitair Ziekenhuis Brussel